Clinical Trial Update: LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LEE001 in combination with Chemoembolization in advanced hepatocellular carcinoma was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LEE001

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-02-01